GlassScriptPhysician profile
Louise Zhou
NPI 1003075490
$1,113.99
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $795 · 2020: $122 · 2022: $25.52 · 2023: $150 · 2024: $21.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $150 · Food and Beverage: $21.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $149.98 |
| Food and Beverage | $21.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $232.71 | 2019-2020 | |
| Janssen Biotech, INC. | $212.77 | 2019-2023 | Rybrevant |
| Novartis Pharmaceuticals Corporation | $94.91 | 2019 | |
| Merck Sharp & Dohme LLC | $50.25 | 2019 | |
| Pfizer INC. | $46.78 | 2022-2024 | |
| Ipsen Biopharmaceuticals, INC | $41.83 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.95 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $40.66 | 2019 | |
| Verastem, INC. | $34.72 | 2019 | |
| Astellas Pharma US INC | $32.65 | 2019 | |
| Incyte Corporation | $31.73 | 2019 | |
| Exelixis INC. | $29.79 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $23.18 | 2019 | |
| Medtronic USA, INC. | $22.46 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.19 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $19.92 | 2019 | |
| Abbvie INC. | $17.67 | 2019 | |
| Secura Bio, INC. | $17.31 | 2019 | |
| Taiho Oncology, INC. | $17.23 | 2019 | |
| Emd Serono, INC. | $16.24 | 2019 | |
| Tersera Therapeutics LLC | $16.08 | 2019 | |
| Amgen INC. | $15.44 | 2019 | |
| Genzyme Corporation | $13.31 | 2019 | |
| Dova Pharmaceuticals | $13.20 | 2019 | |
| Genentech USA, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louise Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.